EW vs SAM · P/E 47, rev $1.39B vs rev $2.01B
Edwards Lifesciences Corp (EW) versus Boston Beer Company Inc (SAM) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Boston Beer Company Inc (SAM) is a beverages - brewers company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported SAM revenue for 2024-12-28 was $2.01B. Net income was $59.7M. Revenue was up 0.2% from 2023-12-30 to 2024-12-28. SAM currently screens at market cap $1.79B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. SAM currently screens at market cap $1.79B.
Not investment advice. Open the EW and SAM stock pages for the full models.
Not investment advice.